QTZM — Quantumzyme Share Price
Last trade - 00:00- $174.94m
- $174.94m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | n/a | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End 31st Jul | Unit | 2021 | 2022 | 2023 | 2024 | 2025 | 2026E | 2027E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Quantumzyme Corp. is a biotransformation company, focused on green chemistry. The Company utilizes customer research to enhance enzyme activity, selectivity, and specificity by applying quantum mechanics, molecular modeling, and engineering approaches. The Company focuses on an approach to all chemical companies to harness the power of technology by simplifying complex chemistry and reducing the number of steps by implementing scientific rationale like quantum mechanics in biology. By integrating computational modeling with wet-lab validation, Quantumzyme delivers biocatalysis solutions that improve industrial sustainability. The Company focuses on solving complex chemistry problems across industry verticals ranging from Pharmaceutical, Fragrances, and Flavors. The Company’s Biocatalysis solution through engineered enzymes involves the application of scientific principles and techniques to modify and optimize the structure and function of enzymes for specific purposes.
Directors
- Last Annual
- July 31st, 2025
- Last Interim
- October 31st, 2025
- Incorporated
- March 20th, 2015
- Public Since
- April 25th, 2017
- Sector
- Chemicals
- Industry
- Basic Materials
- Exchange
- Pink Sheets on Nasdaq
- Shares in Issue
- 38,962,050
- Address
- 15656 Bernardo Center Drive, #801, SAN DIEGO, 92127
- Web
- Phone
- +1 8582030312
- Auditors
- Fruci & Associates II, PLLC
Upcoming Events for QTZM
Similar to QTZM
Advanced Container Technologies
Pink Sheets on Nasdaq
Alkane
Pink Sheets on Nasdaq
Angstrom Technologies
Pink Sheets on Nasdaq
Asia Carbon Industries
Pink Sheets on Nasdaq
BioLargo
Pink Sheets on Nasdaq
FAQ
As of Today at 21:49 UTC, shares in Quantumzyme are trading at $4.49. This share price information is delayed by 15 minutes.
Shares in Quantumzyme last closed at $4.49 and the price had moved by +349% over the past 365 days. In terms of relative price strength the Quantumzyme share price has outperformed the S&P500 Index by +279.28% over the past year.
There is no consensus recommendation for this security.
Find out moreQuantumzyme does not currently pay a dividend.
Quantumzyme does not currently pay a dividend.
Quantumzyme does not currently pay a dividend.
To buy shares in Quantumzyme you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $4.49, shares in Quantumzyme had a market capitalisation of $174.94m.
Here are the trading details for Quantumzyme:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: QTZM
Based on an overall assessment of its quality, value and momentum Quantumzyme is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Quantumzyme. Over the past six months, its share price has outperformed the S&P500 Index by +2449.87%.
As of the last closing price of $4.49, shares in Quantumzyme were trading +286.25% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Quantumzyme PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $4.49.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Quantumzyme's directors